Hepatitis B Virus genotypic differences map structurally close to NRTI resistance hot spots

Despite the availability of a Hepatitis B Virus (HBV) vaccine, there are approximately 350 million people that are chronically infected with this virus that can cause liver cirrhosis and hepatocellular carcinoma. Currently, most approved anti-HBV drugs are nucleoside RT inhibitors (NRTIs) that targe...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Michailidis, Eleftherios, Singh, Kamlendra, Kirby, Karen A., Hachiya, Atsuko, Yoo, Wangdon, Hong, Sun Pyo, Kim, Soo-Ok, Folk, William R., Sarafianos, Stefan G.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2011
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3325108/
https://ncbi.nlm.nih.gov/pubmed/22505793
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller